Eos Advisory’s portfolio reaches £121m valuation as investment firm sees first two exit events in 2021

ST ANDREWS-based investment firm Eos Advisory’s portfolio has reached a total valuation of £121 million based on latest investment rounds, and saw its first two exit events in 2021, including when Genus Plc acquired a large stake in aquaculture specialist Xelect.

In January 2021, Eos announced that it had led a £1.24 million investment into RAB-Microfluidics, an Aberdeen-headquartered R&D company developing cutting-edge microfluidic technology to diagnose engine and turbine wear in real time. Founded by CEO Rotimi Alabi, RAB-Microfluidics has since grown the team and gained significant sales.

In February 2021, Eos secured its first strategic investment partnership with US-based Kineticos Life Sciences, to co-invest in early stage Scottish companies. The venture partnership aims to invest over £10 million over the next five years in oncology-focused life sciences ventures.

In June, sustainable food protein scale-up Enough (previously called 3F BIO), a University of Strathclyde spin-out, secured a $43 million Series B round, one of the largest investment rounds into a Scottish technology company to date.

In July, RNA and DNA genetic sequencing specialist Wobble Genomics, a spin-out from the University of Edinburgh’s Roslin Institute and founded by CEO Richard Kuo, secured a £2.15 million round led by Eos. Wobble has developed a range of hardware and software tools that give scientists and clinicians a more detailed picture of our underlying biology.

The past year has also been focused on building the Eos team including the appointment of Chris Brinsmead CBE, a former senior AstraZeneca executive and former adviser to the UK Government on life sciences, to the firm’s board and Callum Keddie, who previously led a London-based venture capital impact fund, joining Eos as an Investment Executive.

The firm now has three investment pillars in place: the Eos Syndicate, Eos Innovation Fund, and Eos Venture Partnerships. This is part of a wider strategy to support the funding of Scottish innovation beyond the seed stage.

Read more HERE.